Crypto Gloom

Injective’s EVM layer 2 targets Ethereum, Cosmos, and Solana. AI cryptocurrency that goes beyond article expressions attracts whales

The blockchain space is seeing fierce competition for developer mindshare, especially after the emergence of layer 2 solutions and the recent SEC decision on the Bitcoin ETF.

Injective Labs, the team behind the high-speed Injective Protocol, recently entered the fray by releasing inEVM, its own Ethereum Virtual Machine (EVM) Layer 2 rollup. But Injective isn’t the only emerging cryptocurrency project making headlines. A new blockchain ICO contender, InQubeta (QUBE), is generating buzz and attracting significant investor interest for its innovative approach to supporting AI technology startups.

Injection bets on interoperability with inEVM

Following a successful testnet phase, Injective has officially launched EVM on mainnet. This layer 2 solution boasts the ability to achieve true composability across major blockchains such as Ethereum, Cosmos, and Solana, making it a game-changer. This aligns perfectly with Injective’s vision of building a network of “Electro Chains”, essentially expanding the layer 2 ecosystem while improving interoperability across blockchains.

inEVM is a service specifically for Ethereum developers. This is done by allowing you to build decentralized applications (dApps) that take advantage of Injective’s blazing-fast speeds and near-zero transaction fees. The familiar EVM environment and seamless integration with WebAssembly (WASM) opens the door for a wider pool of developers to contribute to the Injective ecosystem.

In retrospect, Injective’s rapid growth is fueled by its status as one of the fastest-growing layer 1 blockchains. However, the team recognized a growing demand for EVM infrastructure from its developer base. inEVM addresses this need by providing a familiar environment with the basic functionality of Injective and the added benefits of plug-and-play modules.

Injective is not alone in embracing the EVM standard. Several other popular blockchain platforms have recently announced similar plans. QuickNode, a leading blockchain infrastructure provider, recently launched Immutable zkEVM, providing developers with a scalable EVM-compatible platform with low transaction costs.

Likewise, Conflux Network has ambitious plans to launch an EVM-compatible Bitcoin Layer 2 solution by May 2024.

InQubeta: AI Cryptocurrency for Leap Forward

While Injective focuses on the developer experience within the blockchain space, InQubeta (QUBE) takes a different but equally innovative approach. The upcoming cryptocurrency ICO platform aims to revolutionize the way AI tech startups raise capital and surpass Injective in the process.

InQubeta helps these startups create investment opportunities with NFTs. These unique digital assets will be listed on InQubeta’s P2P marketplace, allowing investors to trade them and share in the growth of promising AI ventures.

One of the most attractive features for investors is InQubeta’s unique fractional investment model. This innovative approach allows users to diversify their portfolio by investing small amounts in multiple AI startups.

InQubeta’s ongoing presale is gaining significant traction, with the native QUBE tokens selling out quickly. The top ICO projects have already raised over $11.6 million in funding and distributed over 890 million tokens, generating strong investor interest. The current price of QUBE is $0.0245, and when Stage 9 begins, the price is expected to increase to $0.028.

In addition to the popular NFT mining feature, InQubeta offers additional benefits to token holders. The platform features a staking mechanism that allows users to earn passive income from their QUBE holdings. InQubeta isn’t just bringing popular AI startups to NFTs. QUBE token holders can also accumulate coins to receive sweet rewards. With a dedicated pool operating under a 2% purchase tax and 5% sales tax, there is real potential to increase revenue.

conclusion

Both Injective and InQubeta are exciting developments with significant potential. Injective’s inEVM aims to make blockchain development smoother and faster by creating an interoperable environment that works well with EVM. Meanwhile, InQubeta aims to establish itself as one of the top DeFi projects by pioneering a new way for AI startups to raise capital through innovative NFT-based financing.

Visit InQubeta’s website to explore its vision for the future of AI and investing. You too can join in the buzz Twitter Stay up to date with the latest developments through our community.

Visit InQubeta Presale

Join the InQubeta community